NEW YORK (GenomeWeb News) – ACE BioSciences has tapped CLC Bio to develop a customized bioinformatics platform that will support its work in vaccine target discovery and validation, CLC Bio said today.
 
Under the terms of the agreement, CLC Bio will upgrade ACE BioSciences' current bioinformatics platform to ensure that the firm can compare, rank, and prioritize potential vaccine targets.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.